SCHEMBL16834643

SCHEMBL16834643

O=C(O)Nc1cc2cn[nH]c2cc1OC(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 4/20 0.48
▸ TRPM8 Q7Z2W7 2/20 0.48
▸ TRPV1 Q8NER1 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ ROCK2 O75116 4/20 0.39
▸ ROCK1 Q13464 4/20 0.39
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ MKNK1 Q9BUB5 2/20 0.38
▸ AXL P30530 1/20 0.38
▸ RPS6KB1 P23443 1/20 0.37
▸ RPS6KA1 Q15418 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16845644 0.84 TRPA1 (0.44) TRPA1TRPM8TRPV1L3MBTL1MEN1
SCHEMBL16834130 0.82 IRAK4 (0.55) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL27228043 0.79 TRPA1 (0.41) TRPA1TRPM8TRPV1L3MBTL1MEN1
SCHEMBL18168040 0.79 MKNK1 (0.57) TRPA1L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL16834228 0.77 L3MBTL1 (0.49) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18167974 0.77 L3MBTL1 (0.68) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16834315 0.76 L3MBTL1 (0.50) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16834600 0.75 MKNK1 (0.47) MEN1KMT2AALDH1A1MAPTIRAK4
SCHEMBL16834434 0.75 L3MBTL1 (0.49) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16834154 0.75 L3MBTL1 (0.49) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9951086-B2 Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-24 — — US disclosed
US-20160311833-A1 NOVEL INDAZOLECARBOXAMIDES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS COMPRISING THEM AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-10-27 — — US disclosed
EP-3083586-A1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS Bayer Pharma Aktiengesellschaft (DE) 2016-10-26 — — EP disclosed
WO-2015091426-A1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311833-A1 NOVEL INDAZOLECARBOXAMIDES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS COMPRISING THEM AND THEIR USE FOR PRODUCING MEDICAMENTS MALT1, APC, UACA TRPA1 2200/4885TRPM8 1986/4885TRPV1 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback